Novo Nordisk: 'on track' to meet long-term financial targets

(CercleFinance.com) - At its Capital Markets Day on Wednesday, Danish drugmaker Novo Nordisk said it expects to meet its long-term financial targets.


The world's biggest insulin producer said that it is on track to meet its current goals, including average operating profit growth of 5%, cash-to-earnings of 85% (a three-year average) and operating profit after tax over net operating assets of 80%.

The shares, however, are currently down about 1.5% on Cophenagen's Nasdaq Nordic market.

Copyright (c) 2019 CercleFinance.com. All rights reserved.